Search

everythinglearnresearchcommunity

for

Search:↓

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Ayurveda can help treat premature hair graying with lifestyle changes and herbal remedies.

Many people in Saudi Arabia use vitamin D supplements, but few experience toxicity, showing the need for professional guidance when taking these supplements.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

A horse in Brazil had seasonal hair loss possibly linked to light exposure and melatonin levels.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

About 61% of women who had COVID-19 experienced hair loss afterward.

COVID-19 infection may cause hair loss.

Vitiligo and lupus can occur together, requiring careful treatment to manage both conditions.

Taurine is important for many body functions and its deficiency can cause health problems.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Yoga and Ayurveda, including stress management and herbal oil use, can potentially reduce hair loss and promote hair growth, with further research needed for therapy protocols.